Molecular Characterization of Ongoing Enzymatic Reactions in Raw Garlic Cloves Using Extractive

Molecular Characterization of Ongoing Enzymatic Reactions in Raw Garlic Cloves Using Extractive

<p> Supporting Information</p><p>Preconcentration of organic solutes in urine by bubble bursting</p><p>S-1 Supplementary Tables</p><p>Table S-1. Signal enrichment factor (R = Ibubble/Ibulk) of phenylalanine (Phe, 100 µM) and arginine (Arg, 20 µM) in aqueous solutions by bursting bubbles produced using diffusers with different porosity. Bubble path length was 100 cm.</p><p>Table S-2. Signal enrichment factor (R = Ibubble/Ibulk) of Arg in aqueous solution (20 µM) by bursting bubbles produced using diffusers with different porosity depending on the path length of rising bubbles. Mode 1 = porosity 100 µm; mode 2 = porosity 1-10 µm; mode 3 = porosity 0.2-5 µm.</p><p>S-2 Table S-3. Urine metabolites detected by the high-resolution mass spectrometry of aerosols produced by bubble bursting. *Identification additionally verified by tandem mass spectrometry of authentic compound. **HMDB chemical classification was used. See Table S-4. No HMDB ID Formula R[M+H]+ R[M+Na]+ MS/MS* Chemical category** 1 15334 C17H27NO4 10.1±1.1 + 1-1-0 2 14592 C19H29NO5 9.1±1.3 1-2-1 3 15639 C17H23N3O 7.4±1.2 1-2-2 4 14531 C19H29NO 1-2-2 5 15374 C24H34N2O 1-2-2 6 13835 C16H22O4 6.8±1.2 0.9±0.3 1-2-3 7 02107 C8H6O4 6.0±0.9 1-2-3 8 14018 C12H18O2 6.7±1.2 1-2-4 9 14956 C12H18O 1-2-4 10 29226 C12H14O4 4.4±0.8 1-2-5 11 00118 C9H10O4 1-2-5 12 15145 C10H16NO 1-2-5 13 14538 C14H18N4O3 1-2-6 14 15114 C17H25NO3 1-2-7 15 15039 C13H12Cl2O4 1-2-8 16 14909 C22H26NO3 1-2-9 17 13973 C22H31NO2 1-2-9 18 14708 C26H28N2 1-2-9</p><p>S-3 19 15589 C26H26F2N2 1-2-9 20 15120 C24H28ClN5O3 1-2-9 21 14486 C32H41NO2 1-2-9 22 15590 C29H31F2N3O 1-2-9 23 60905 C21H21ClFNO 1-2-10 24 13961 C26H36N2O4 1-2-10 25 01850 C27H38N2O4 1-2-10 26 15406 C20H27N5O5S 1-2-11 27 13862 C28H29N7O 1-2-12 28 15631 C25H32N2O4 0.7±0.1 2-1-1 29 15543 C21H33N3O5S 9.5±1.3 2-1-1 30 00001 C7H11N3O2 8.4±1.3 + 2-1-1 31 00194 C10H16N4O3 8.0±1.3 1.5±0.3 + 2-1-1 32 00177 C6H9N3O2 5.4±0.5 + 2-1-1 33 00182 C6H14N2O2 5.3±0.5 + 2-1-1 34 04827 C7H13NO2 2-1-1 35 14388 C24H33N3O4 2-1-1 36 00791 C15H29NO4 15±0.9 3-1-1 37 13205 C17H31NO4 12.3±1.1 3-1-1 38 02013 C11H21NO4 11.3±1.1 0.7±0.2 3-1-1 39 00378 C12H23NO4 7.8±1.3 3-1-1 40 34708 C11H18O2 7.2±1.1 3-1-1 41 00756 C13H25NO4 3-1-1 42 00651 C17H33NO4 3-1-1 43 13330 C21H39NO5 13.5±1.3 3-1-2 44 60682 C8H12O2 10.9±1.2 3-1-2 45 00784 C9H16O4 9.8±1.3 3-1-2 46 00482 C8H16O2 8.0±1.3 3-1-2 47 59731 C7H8O4 3-1-2 48 00341 C8H12O4 3-1-2 49 00933 C12H20O4 3-1-2 50 00394 C14H26O5 3-1-2 51 02183 C22H32O2 3-1-2 52 01220 C20H32O5 11.7±1.1 + 3-1-3 53 05079 C20H28O3 3-1-3 54 03876 C20H32O3 3-1-3 55 01085 C20H32O4 3-1-3 56 01139 C20H34O5 3-1-3 57 04238 C20H30O4 3-1-3 58 02277 C18H30O6 3-1-3 59 02904 C18H30O6 1.7±0.3 3-1-3 60 00526 C21H34O5 14.1±0.4 3-2-1 61 00903 C21H32O5 13.2±1.2 3-2-1 62 00037 C21H28O5 12.7±1.1 + 3-2-1</p><p>S-4 63 61016 C21H28O6 3-2-1 64 61106 C25H34O7 3-2-1 65 02472 C32H51NO12 12±1.0 3-2-2 66 10320 C27H42O11 11.5±1.0 3-2-2 67 02829 C25H38O8 3-2-2 68 02596 C30H48O10 3-2-2 69 00374 C21H30O3 3-2-3 70 00315 C21H32O3 3-2-3 71 60708 C24H29ClO5 3-2-3 72 15181 C26H32F2O7 3-2-3 73 15676 C27H34F2O7 3-2-3 74 00053 C19H26O2 3-2-4 75 00077 C19H28O2 3-2-4 76 15446 C21H26O2 3-2-5 77 14511 C21H28O2 3-2-5 78 01926 C20H24O2 3-2-5 79 14855 C20H26O2 3-2-5 80 00380 C19H26O3 3-2-5 81 15327 C23H31Cl2NO3 3-2-5 82 14972 C29H35NO2 3-2-6 83 14652 C43H66O14 3-2-7 84 13817 C14H20O2 6.5±1.1 3-3-1 85 04586 C10H14O2 5.7±0.6 3-3-1 86 01878 C10H14O 5.5±0.5 3-3-1 87 32913 C13H22O 3-3-2 88 15643 C16H26O5 3-3-2 89 04808 C18H18O4 3-3-3 90 04602 C21H26O3 3-3-4 91 03141 C26H36O8 3-3-5 92 10344 C34H52O7 3-3-6 93 15293 C19H25N5O4 10.5±1.1 1.4±0.3 4-1-1 94 61107 C21H31N5O3 4-1-1 95 15488 C30H26F6N4O2 4-1-1 96 15194 C20H23N5O6S 9.4±1.4 4-2-1 97 14723 C12H21N5O2S2 9.0±1.3 0.7±0.1 4-3-1 98 14934 C24H20N6O3 4-3-2 99 13845 C25H30N6O2 4-3-2 100 00562 C4H7N3O 8.7±1.3 + 4-4-1 101 14862 C14H16N4 8.6±1.3 4-5-1 102 14746 C18H26ClN3 4-5-1 103 14668 C20H29N3O2 4-5-2 104 04158 C33H42N4O6 8.5±1.3 1.3±0.1 + 4-6-1 105 13824 C9H14O 7.9±1.3 4-7-0 106 35907 C10H18O2 7.6±1.2 4-8-0</p><p>S-5 107 14868 C10H7N3S 7.5±1.1 + 4-9-0 108 04193 C7H8N2O2 6.3±1.1 1.4±0.2 + 4-10-1 109 14597 C15H21NO2 6.3±1.0 + 4-11-1 110 15238 C26H29FN2O2 4-11-1 111 15400 C8H8N4 4-12-1 112 15104 C17H18N4O 4-13-1 113 14671 C22H23N3O4 4-13-2 114 15267 C24H26N2O4 4-13-2 115 14864 C20H26N2 4-14-1 116 60717 C25H32N2O7 4-14-1 117 14629 C24H36O3 4-15-1 118 15172 C23H29N3O2S 4-16-1 119 61012 C20H18F7NO2 4-17-1 120 00451 C8H14O3 9.7±1.3 5-1-1 121 29165 C7H12O2 9.2±1.4 5-2-1 122 13821 C9H18O 5-2-1 123 60705 C21H22N4O8 7.9±1.4 5-3-1 124 60498 C16H24N3O8 5-3-1 125 00122 C6H12O6 6.7±1.2 + 5-3-2 126 15090 C21H41N5O7 5-3-3 127 14936 C21H43N5O7 5-3-3 128 00158 C9H11NO3 5.0±0.4 1.2±0.1 + 6-1-0 129 14913 C22H36N2O5S 6-1-0 130 29865 C9H6O3 4.2±1.0 6-2-1 131 15487 C19H15NO6 6-2-1 132 02899 C14H6O8 6-3-1 133 15593 C27H42N2O5S 6-4-1</p><p>Table S-4. Chemical categories of urine metabolites in Table S-3 according to HMDB classification. superclass class subclass 1 Benzenoids 1-1 Tetralins 1-2 Benzene and 1-2-1 Phenol esters</p><p>S-6 substituted derivatives 1-2-2 Phenylmethylamines 1-2-3 Benzoic acids and derivatives 1-2-4 Cumenes 1-2-5 Phenols and derivatives 1-2-6 Phenol ethers 1-2-7 Phenylacetic acid derivatives 1-2-8 Phenoxyacetic acid derivatives 1-2-9 Diphenylmethanes 1-2-10 Phenylbutylamines 1-2-11 Benzenesulfonamides 1-2-12 Benzamides 2 Organic acids 2-1 Carboxylic acids 2-1-1 Amino acids, and derivatives and derivatives peptides, and analogues 3 Lipids and 3-1 fatty acyls 3-1-1 fatty acid esters lipid-like molecules 3-1-2 Fatty acids and conjugates 3-1-3 Eicosanoids 3-2 Steroids and 3-2-1 Hydroxysteroids steroid derivatives 3-2-2 Steroidal glycosides 3-2-3 Pregnane steroids 3-2-4 Androstane steroids 3-2-5 Estrane steroids 3-2-6 Oxosteroids 3-2-7 Steroid lactones 3-3 Prenol lipids 3-3-1 Monoterpenoids 3-3-2 Sesquiterpenoids 3-3-3 Quinone and hydroquinone lipids 3-3-4 Retinoids 3-3-5 Terpene glycosides 3-3-6 Triterpenoids 4 4-1 Diazinanes 4-1-1 Piperazines</p><p>S-7 Organoheterocycli c compounds 4-2 Lactams 4-2-1 Beta lactams 4-3 Azoles 4-3-1 Thiazoles 4-3-2 Tetrazoles 4-4 Azolines 4-4-1 Imidazolines 4-5 Quinolines and 4-5-1 Aminoquinolines derivatives and derivatives 4-5-2 Quinoline carboxamides 4-6 Tetrapyrroles and 4-6-1 Bilirubins derivatives 4-7 Heteroaromatic compounds 4-8 Oxolanes 4-9 Benzimidazoles 4-10 Pyridines and 4-10-1 derivatives Pyridinecarboxylic acids and derivatives 4-11 Piperidines 4-11-1 Phenylpiperidines 4-12 Naphthyridines 4-12-1 Phthalazines 4-12-2 Quinazolines 4-13 Indoles and 4-13-1 Indoles derivatives 4-13-2 Carbazoles 4-14 Benzazepines 4-14-1 Dibenzazepines 4-15 Naphthopyrans 4-15-1 Naphthopyranones 4-16 Benzothiazines 4-16-1 Phenothiazines 4-17 Oxazinanes 4-17-1 Morpholines 5 Organooxygen 5-1 Alcohols and 5-1-1 Secondary alcohols compounds polyols 5-2 Carbonyl compounds 5-2-1 Ketones 5-3 Carbohydrates and 5-3-1 Sugar acids and carbohydrate conjugates derivatives 5-3-2 Monosaccharides 5-3-3 Aminosaccharides 6 6-1 Phenylpropanoic Phenylpropanoids acids and polyketides 6-2 Coumarins and 6-2-1 Hydroxycoumarins derivatives 6-3 Tannins 6-3-1 Hydrolyzable tannins </p><p>S-8 6-4 Macrolides and 6-4-1 Epothilones and analogues analogues </p><p>Table S-5. The enrichment of signal intensity (R) and signal-to-noise ratio (S/N) for clenbuterol (Cle) and salbutamol (Sal) in urine by bubble bursting with different gases. Detection was done on LTQ-MS. </p><p>Supplementary Figure</p><p>S-9 Fig. S-1 Signal enrichment (R = Ibubble/Ibulk) for the protonated species of urine metabolites across m/z domain.</p><p>S-10</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us